clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT00208793 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P17 | country | United States of America | Q30 |
P582 | end time | 2006-09-01 | |
P921 | main subject | Colon Cancer Prevention by Detection of APC Gene Mutation in a Family with Attenuated Familial Adenomatous Polyposis | Q57002440 |
P4135 | maximum age | 74 | |
P2899 | minimum age | 30 | |
P1132 | number of participants | 92 | |
P4844 | research intervention | calcium carbonate | Q23767 |
calcium oxalate | Q412399 | ||
(5R)-24,25-Dihydroxyvitamin D | Q27161510 | ||
P1813 | short name | CaDvMAP | |
P580 | start time | 2005-05-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Calcium, Vitamin D, and Colon Cancer Risk Biomarkers |
Search more.